1. Academic Validation
  2. Nicotinamide Phosphoribosyltransferase Positive Allosteric Modulators Attenuate Neuronal Oxidative Stress

Nicotinamide Phosphoribosyltransferase Positive Allosteric Modulators Attenuate Neuronal Oxidative Stress

  • ACS Med Chem Lett. 2024 Jan 24;15(2):205-214. doi: 10.1021/acsmedchemlett.3c00391.
Jesse Gordon-Blake 1 Kiira Ratia 1 1 Victoria Weidig 1 Ganga Reddy Velma 2 Martha Ackerman-Berrier 2 Christopher Penton 2 Soumya Reddy Musku 2 Erick T M Alves 2 Tom Driver 1 Leon Tai 1 Gregory R J Thatcher 2
Affiliations

Affiliations

  • 1 Department of Pharmaceutical Sciences, Research Resources Center, Department of Chemistry, and Department of Anatomy and Cell Biology, University of Illinois at Chicago, Chicago, Illinois 60612, United States.
  • 2 Department of Pharmacology & Toxicology, R Ken Coit College of Pharmacy, University of Arizona, Tucson, Arizona 85721, United States.
Abstract

Evidence supports boosting nicotinamide adenine dinucleotide (NAD+) to counteract oxidative stress in aging and neurodegenerative disease. One approach is to enhance the activity of nicotinamide phosphoribosyltransferase (NAMPT). Novel NAMPT positive allosteric modulators (N-PAMs) were identified. A cocrystal structure confirmed N-PAM binding to the NAMPT rear channel. Early hit-to-lead efforts led to a 1.88-fold maximum increase in the level of NAD+ in human THP-1 cells. Select N-PAMs were assessed for mitigation of Reactive Oxygen Species (ROS) in HT-22 neuronal cells subject to inflammatory stress using tumor necrosis factor alpha (TNFα). N-PAMs that increased NAD+ more effectively in THP-1 cells attenuated TNFα-induced ROS more effectively in HT-22 cells. The most efficacious N-PAM completely attenuated ROS elevation in glutamate-stressed HT-22 cells, a model of neuronal excitotoxicity. This work demonstrates for the first time that N-PAMs are capable of mitigating elevated ROS in neurons stressed with TNFα and glutamate and provides support for further N-PAM optimization for treatment of neurodegenerative diseases.

Figures
Products